HomeLYRA • NASDAQ
add
Lyra Therapeutics Inc
Previous close
$4.19
Day range
$3.93 - $4.33
Year range
$2.84 - $37.50
Market cap
7.63M USD
Avg Volume
71.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 25.00K | -87.18% |
Operating expense | 2.24M | -43.12% |
Net income | -5.98M | 49.60% |
Net profit margin | -23.94K | -293.12% |
Earnings per share | -3.40 | 50.95% |
EBITDA | -6.15M | 35.89% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.06M | -57.28% |
Total assets | 43.71M | -44.50% |
Total liabilities | 48.04M | -17.37% |
Total equity | -4.33M | — |
Shares outstanding | 1.77M | — |
Price to book | -1.59 | — |
Return on assets | -32.50% | — |
Return on capital | -51.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.98M | 49.60% |
Cash from operations | -7.36M | 54.63% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -368.00K | -1,500.00% |
Net change in cash | -7.73M | 4.64% |
Free cash flow | -5.27M | 44.39% |
About
Founded
2005
Headquarters
Website
Employees
30
